Craig W. Moore, Director at NxStage Medical, Inc. (NXTM), sold 4,000 shares at $19.60 ($78K) on 2015-11-18, disclosed to the SEC on 2015-11-18.
Scheduled sale ($78k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NXTM | SELL | 2015-11-20 | $20K | — | Filing → |
| NXTM | SELL | 2015-09-16 | $16K | — | Filing → |
| NXTM | SELL | 2011-12-19 | $173K | — | Filing → |